Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Targeted treatment of solid tumors and hematologic malignancies.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Targeted treatment of solid tumors and hematologic malignancies.
Approved for use in oncology care according to FDA-approved indications.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Hodgkin Lymphoma, CD30-expressing T-cell lymphomas, Urothelial Carcinoma, Cervical Cancer, or Diffuse Large B-cell Lymphoma.
Adult patients with unresectable or metastatic HER2-positive breast cancer, HER2-low breast cancer, HER2-mutant metastatic NSCLC, and locally advanced or metastatic HER2-positive gastric adenocarcinoma.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
NTRK gene fusion-positive solid tumors across all tissue origins.